A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Part of paid clinical trials in Fairhope, Alabama.

Sponsor
Colorado Prevention Center
Study ID
NCT06024746
Phase
PHASE3
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

Combination therapy of finerenone plus empagliflozin will be compared to usual care to determine the efficacy and safety of treatment in patients hospitalized with heart failure.

Key Dates

First listed
Sep 6, 2023
Start date
Jul 9, 2024
Status verified
Jul 2026
Primary completion
Nov 30, 2027
Completion
Nov 30, 2027

Study Design

Enrollment
1,500 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Finerenone plus empagliflozin
  • No Intervention: Usual care
    Usual care management

Primary Outcome Measure

Clinical benefit [ Time Frame: 6 months ]

Central Contacts

Locations (33)

FacilityCityStateZIPSite coordinators
CON-10004 Fairhope, AL Investigational SiteFairhopeAlabama36532-
CON-10075 El Centro, CA Investigational SiteEl CentroCalifornia92243-
CON-10024 Sacramento, CA Investigational SiteSacramentoCalifornia95816-
CON-10023, San Francisco, CASan FranciscoCalifornia94118
Bonaca, MD
+1-303-860-9900
CON-10109, Van Nuys, CAVan NuysCalifornia91405
Bonaca, MD
+1-303-860-9900
CON-10001, Aurora, COAuroraColorado80045
Bonaca, MD
+1-303-860-9900
CON-10005, Denver, CODenverColorado80204
Bonaca, MD
+1-303-860-9900
CON-10078, Hialeah, FLHialeahFlorida33012
Bonaca, MD
+1-303-860-9900
CON-10105, Miami, FLMiamiFlorida33135
Bonaca, MD
+1-303-860-9900
CON-10113, Miramar, FLMiramarFlorida33027
Bonaca, MD
3038609900
CON-10022 Atlanta, GA Investigational SiteAtlantaGeorgia30303-
CON-10021, Glenview, ILGlenviewIllinois60026
Bonaca, MD
+1-303-860-9900
CON-10041, Island Lake, ILIsland LakeIllinois60042
Bonaca, MD
+1-303-860-9900
CON-10025, Naperville, ILNapervilleIllinois60540
Bonaca, MD
+1-303-860-9900
CON-10019, Peoria, ILPeoriaIllinois61603
Bonaca, MD
+1-303-860-9900
CON-10064, Merrillville, INMerrillvilleIndiana46410
Bonaca, MD
+1-303-860-9900
CON-10080, Lexington, KYLexingtonKentucky40503
Bonaca, MD
+1-303-860-9900
CON-10086, Louisville, KentuckyLouisvilleKentucky40205
Bonaca, MD
3038609900
CON-10079, Paducah, KYPaducahKentucky42003
Bonaca, MD
+1-303-860-9900
CON-10030 Baton Rouge, LA Investigational SiteBaton RougeLouisiana70808-
CON-10090, West Monroe, LAWest MonroeLouisiana71291
Bonaca, MD
3038609900
CON-10002 Kansas City, MO Investigative SiteKansas CityMissouri64111
Marc Bonaca
CON-10018, Omaha, NEOmahaNebraska68105
Bonaca, MD
+1-303-860-9900
CON-10318, Charlotte, NCCharlotteNorth Carolina28207
Bonaca, MD
+1-303-860-9900
CON-10119, Centerville, OHCentervilleOhio45459
Bonaca, MD
+1-303-860-9900
CON-10051, Chattanooga, TNChattanoogaTennessee37403
Bonaca, MD
+1-303-860-9900
CON-10045 Amarillo, TX Investigational SiteAmarilloTexas79106-
CON-10015 Austin, TX Investigational SiteAustinTexas78705-
CON-10304, Denison, TXDenisonTexas75020
Bonaca, MD
3038609900
CON-10301, Fort Worth, TXFort WorthTexas76104
Bonaca, MD
+1-303-860-9900
CON-10085, Houston, TXHoustonTexas77030
Bonaca, MD
+1-303-860-9900
CON-10305, Layton, UTLaytonUtah84041
CON-10009, Norfolk, VANorfolkVirginia23507
Bonaca, MD
+1-303-860-9900

Find similar trials in Fairhope, AL

By condition

Related Studies